Image

Orthopaedic Specimen Pathology and Early Diagnosis of ATTR Cardiopathy (ATTR-ORTHO)

Recruiting
50 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of this observational study is to learn about the frequency of ATTR amyloid, cardiac involvement and associated features, in 150 patients aged 50 or more years, and operated for an idiopathic carpal tunnel syndrome, lumbar spine stenosis or total hip or knee arthroplasty for primary osteoarthritis. The main questions to be answered are:

  1. What is the frequency of ATTR deposits in samples retrieved during surgery?
  2. What is the frequency of cardiac involvement in ATTR positive patients?
  3. What are the preoperative predictors of ATTR deposits? Participants will
    • have operative samples stained by Congo red in search of amyloid, which will be typed by immunochemistry in positive samples,
    • undergo a multimodal imaging search for cardiac involvement, if ATTR is identified,
    • undergo a preoperative complete clinical examination, including collection of medical history, ECG, biochemical tests, and imaging (ultrasound scans of rotator cuff and hip capsule in all participating patients, of the carpal tunnel in patients operated at this site, and MRI + standing profile radiography of the lumbar spine, in patients operated for lumbar stenosis)
    • ATTR positive patients will be proposed to be followed-up by a reference center, with the aim of an early diagnosis of cardiac involvement, allowing efficient mamagement.

Researchers will assess the frequency of ATTR deposits at each operated site, the frequency or ATTR cardiopathy in ATTR + patients, and will compare demographic, clinical, biochemical, and imaging features in patients with and without ATTR deposits, to guide the indications of pathological examination during these frequent orthopedic surgeries

Eligibility

Inclusion Criteria:

  1. patients aged 50 or over
  2. having signed an informed consent form
  3. undergoing surgery for
    1. idiopathic carpal tunnel syndrome
    2. or lumbar spinal canal stenosis
    3. or prosthetic replacement of a hip or knee for primary osteoarthritis

Exclusion Criteria:

  1. secondary carpal tunnel syndrome (inflammatory rheumatism, diabetes, hypothyroidism, etc.)
  2. Indication of prosthesis for a condition other than primary osteoarthritis.
  3. Known amyloidosis
  4. Refusal of consent
  5. Inability to understand the study
  6. Age < 50 years

Study details

ATTR Amyloidosis, Cardiopathy, Carpal Tunnel Syndrome, Lumbar Spine Stenosis, Hip Prosthesis

NCT06367842

Institut Mutualiste Montsouris

2 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.